#CADILAHC has received tentative approval from the USFDA to market Carbidopa and Levodopa extended release capsules and stock became rocket and break the level 400 that was strong resistance. Currently stock closed above 400 level.
Showing Bullish result in Technical Parameter: CCI in overbought zone RSI crossed above 70 MFI crossed above 80 Stoch in overbought zone Making higher high since 3 days DI+ treading above DI- New Long position ---------------------------------------------------------- Resistance : 410 & 420 & 433 Breakout : 406 LTP : 404.90 Breakdown : 399.75 Support : 390 & 385 & 374 ---------------------------------------------------------- Positive & Negative Point: 1) Very Bullish in Daily/Weekly/Monthly chart. ---------------------------------------------------------- (Disclaimer: This is only for educational purpose and paper treading. Learn and take advice from you financial advisor)
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.